Terrifying Terror Policy

Terrifying Terror Policy In reference to the editor's comments on bioterrorism in the United States,1 I would extend his comments and suggest that the US government is scaring the living s--- out of the US population and for little reason. Why significantly compromise your life's enjoyment by worrying about dying, especially when the risks you are scared about are small compared with real and quantifiable risks, such as auto accidents and myocardial infarctions? Scaring the public has hist

Written byJames Vrbanac
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In reference to the editor's comments on bioterrorism in the United States,1 I would extend his comments and suggest that the US government is scaring the living s--- out of the US population and for little reason. Why significantly compromise your life's enjoyment by worrying about dying, especially when the risks you are scared about are small compared with real and quantifiable risks, such as auto accidents and myocardial infarctions?

Scaring the public has historically been shown to be an effective weapon against reason and an effective means to promote enemy identification, which primates are great at doing. The 20th century offers some notable examples.

James Vrbanac, PhD
Portage, Mich.
johnjames@chartermi.net

***

Excellent article in The Scientist on bioterrorism.1 Surely, scientists should use their analytical training to judge likelihoods, to prioritize politically, and to help the public distinguish data from hysteria.

Is the scientific community being played like a fiddle? ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies